Vesicare Tablets 2.5mg, manufactured by Astellas Pharma, contain Solifenacin succinate and are used for the symptomatic treatment of overactive bladder. This includes addressing symptoms such as urinary urgency, frequent urination, and urge incontinence, with a YJ code of 2590011F1028 and a standard of 2.5mg per tablet.
Vesicare Tablets 2.5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More with the same ingredient
